Treatment of catatonia with methylphenidate in an elderly patient with depression

Psychosomatics

Volumn 51, Issue 1, 2010, Pages 74-76

  Prowler, Matthew L ^a   Weiss, David ^a   Caroff, Stanley N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; METHYLPHENIDATE;

AGED; APATHY; ARTICLE; CASE REPORT; CATATONIA; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN;

EID: 75849151182     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.51.1.74     Document Type: Article

References (17)

1. Taylor MA, Abrams R: Catatonia. prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977; 34:1223-1225
2. Kahlbaum KL: Klinische Abhandlungen uber psychische Krankheiten, 1: Heft: Die Katatonie oder das Spannungsirresein. Berlin, Germany, Hirschwald, 1874
3. Hawkins JM, Archer KJ, Strakowski SM, et al: Somatic treatment of catatonia. Int J Psychiatry Med 1995; 25:345-369
4. Rohland BM, Carroll BT, Jacoby RG: ECT in the treatment of the catatonic syndrome. J Affect Disord 1993; 29:255-261
5. Fricchione GL, Cassem NH, Hooberman D, et al: Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983; 3:338-342
6. McEvoy JP, Lohr JB: Diazepam for catatonia. Am J Psychiatry 1984; 141:284-285
7. Padala PR, Burke WJ, Bhatia SC, et al: Treatment of apathy with methylphenidate. J Neuropsychiatry Clin Neurosci 2007; 19: 81-83
8. Lavretsky H, Park S, Siddarth P, et al: Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial. Am J Geriatr Psychiatry 2006; 14:181-185
9. Rosebush PI, Mazurek MF: Pharmacotherapy, in Catatonia: From Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, et al. Washington, DC, American Psychiatric Publishing, 2004, pp 141-150
10. Sackeim HA, Decina P, Prohovnik I, et al: Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 1983; 18:1301-1310
11. Fricchione GL: Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry 1985; 20:304-313
12. Windels F, Kiyatkin EA: GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons. Neuroscience 2006; 140:1289-1299
13. Carroll BT, Thomas C, Tugrul KC, et al: GABA(A) versus GABA(B) in catatonia. J Neuropsychiatry Clin Neurosci 2007; 19:484
14. Gelenberg AJ, Mandel MR: Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977; 34:947-950
15. Northoff G, Eckert J, Fritze J: Glutamatergic dysfunction in catatonia? successful treatment of three acute akinetic catatonic patients with the NMDA-antagonist amantadine. J Neurol Neurosurg Psychiatry 1997; 62:404-406
16. Mahmood T: Bromocriptine in catatonic stupor. Br J Psychiatry 1991; 158:437-438
17. Bush G, Fink M, Petrides G, et al: Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136